ÂÜÀòÂÒÂ×

YongQi Mu has a strong background in chemistry, with experience in various companies such as Eyconis, Inc, Ascendis Pharma, Relypsa, Nektar Therapeutics, and Theravance. Mu holds a Ph.D. in Medicinal Chemistry from Wayne State University and completed a postdoc at Stanford University. Mu has held titles such as Vice President, Senior Director, Head of Development Chemistry, Associate Director, and Principal Scientist throughout their career.